Rate My Professor Andre Ng

Ng's career encompasses extensive leadership roles, including President of the British Cardiovascular Society since 2024, Director of the British Heart Foundation Leicester Centre of Research Excellence, Vice President (Research and Education) and Chair of the Programme Committee for the British Cardiovascular Society, Non-Executive Director of Northampton General Hospital NHS Trust, and positions on committees such as NICE Interventional Procedures Programme, JRCPTB Specialist Advisory Committee in Cardiology, and BHF Project Grants Committee. He pioneered an active atrial fibrillation ablation programme at Glenfield Hospital in 2002, introduced novel robotic systems for atrial fibrillation ablation, and specializes in advanced device implantations including pacemakers, implantable cardioverter defibrillators, and cardiac resynchronisation therapy devices. Key publications include Kirchhof P et al., 'Early Rhythm-Control Therapy in Patients with Atrial Fibrillation' (New England Journal of Medicine, 2020); Ng GA et al., 'LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use' (Europace, 2018); and Li X et al., 'Standardizing Single-Frame Phase Singularity Identification Algorithms and Parameters in Phase Mapping During Human Atrial Fibrillation' (Frontiers in Physiology, 2020). His innovations earned the Medical Futures Award 2011 for Best Innovation in Diagnostics and the European Heart Rhythm Association Inventors Award 2016. Ng is a Fellow of the Royal Colleges of Physicians (Glasgow and London), European Society of Cardiology, European Heart Rhythm Association, and Higher Education Academy. As national chief investigator and principal investigator for clinical trials, he has advanced cardiovascular guidelines and patient care.